Risk Prediction for Ischemic Stroke and Transient Ischemic Attack in Patients Without Atrial Fibrillation: A Retrospective Cohort Study
Tài liệu tham khảo
Centers for Disease Control and Prevention
Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke, 22, 983, 10.1161/01.STR.22.8.983
Hart, 2001, Atrial fibrillation and stroke: concepts and controversies, Stroke, 32, 803, 10.1161/01.STR.32.3.803
Go, 2001, Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study, JAMA, 285, 2370, 10.1001/jama.285.18.2370
Pearce, 2000, Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation, Am J Med, 109, 45, 10.1016/S0002-9343(00)00440-X
Atrial Fibrillation Investigators, 1994, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized clinical trials, Arch Intern Med, 154, 1949
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators, 1998, Patients with nonvalvular atrial fibrillation at low-risk of stroke during treatment with aspirin, JAMA, 279, 1273, 10.1001/jama.279.16.1273
Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA, 285, 2864, 10.1001/jama.285.22.2864
Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation, Chest, 137, 263, 10.1378/chest.09-1584
Camm, 2012, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation, Eur Heart J, 33, 2719, 10.1093/eurheartj/ehs253
January, 2014, 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, Circulation, 130, 2071, 10.1161/CIR.0000000000000040
National Institute for Health and Care Excellence
Reiffel, 2014, Atrial fibrillation and stroke: epidemiology, Am J Med, 127, e15
Yuan, 2015, Incidence of ischemic stroke or transient ischemic attack in patients with multiple risk factors with or without atrial fibrillation: a retrospective cohort study, Curr Med Res Opin, 31, 1257, 10.1185/03007995.2015.1041469
Hughes, 2008, Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data, Thromb Haemost, 99, 295, 10.1160/TH07-08-0508
Bunch, 2013, Atrial fibrillation ablation patients have longterm stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score, Heart Rhythm, 10, 1272, 10.1016/j.hrthm.2013.07.002
Thigpen, 2015, Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation, Circ Cardiovasc Qual Outcomes, 8, 8, 10.1161/CIRCOUTCOMES.113.000371
Hanley, 1982, The meaning and use of the area under a receiver operating characteristic (ROC) curve, Radiology, 143, 29, 10.1148/radiology.143.1.7063747
Cook, 2007, Use and misuse of the receiver operating characteristic curve in risk prediction, Circulation, 115, 928, 10.1161/CIRCULATIONAHA.106.672402
Suchard, 2013, Massive parallelization of serial inference algorithms for a complex generalized linear model, ACM Trans Model Comput Simul, 23, 1, 10.1145/2414416.2414791
R Foundation for Statistical Computing, 2015
Schuemie
Voss, 2015, The impact of standardizing the definition of visits on the consistency of multi-database observational health research, BMC Med Res Methodol, 15, 13, 10.1186/s12874-015-0001-6
Voss, 2015, Feasibility and utility of applications of the common data model to multiple, disparate observational health databases, J Am Med Inform Assoc, 22, 553, 10.1093/jamia/ocu023
Durrant, 2013, Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives, Expert Rev Cardiovasc Ther, 11, 77, 10.1586/erc.12.161
Chao, 2015, Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-Vasc score (beyond sex) receive oral anticoagulation?, J Am Coll Cardiol, 65, 635, 10.1016/j.jacc.2014.11.046
Keogh, 2011, Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke: a systematic review and meta-analysis, Thromb Haemost, 106, 528, 10.1160/TH11-02-0061
Chen, 2013, CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis, J Geriatr Cardiol, 10, 258
Ohira, 2006, Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study, Stroke, 37, 2493, 10.1161/01.STR.0000239694.19359.88
Lip, 2013, Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a nonatrial fibrillation population: the Chin-Shan Community Cohort Study, Int J Cardiol, 168, 414, 10.1016/j.ijcard.2012.09.148
Welles, 2011, The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study, Am Heart J, 162, 555, 10.1016/j.ahj.2011.05.023
Ntaios, 2013, CHADS(2), CHA(2)S(2)DS(2)-VASc, and long-term stroke outcome in patients without atrial fibrillation, Neurology, 80, 1009, 10.1212/WNL.0b013e318287281b
Fisher, 1992, The accuracy of Medicare's hospital claims data: progress has been made, but problems remain, Am J Public Health, 82, 243, 10.2105/AJPH.82.2.243
Wahl, 2010, Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population, Pharmacoepidemiol Drug Saf, 19, 596, 10.1002/pds.1924
